These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 16391877
21. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW. Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071 [Abstract] [Full Text] [Related]
22. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest. Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N. Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499 [Abstract] [Full Text] [Related]
23. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride. Weihrauch M, Benicke M, Lehnert G, Wittekind C, Wrbitzky R, Tannapfel A. Br J Cancer; 2001 Apr 06; 84(7):982-9. PubMed ID: 11286481 [Abstract] [Full Text] [Related]
24. Abnormal expression of JUNB gene in hepatocellular carcinoma. Chang YS, Yeh KT, Yang MY, Liu TC, Lin SF, Chan WL, Chang JG. Oncol Rep; 2005 Mar 06; 13(3):433-8. PubMed ID: 15706412 [Abstract] [Full Text] [Related]
25. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH. Cancer Epidemiol Biomarkers Prev; 2008 Sep 06; 17(9):2260-7. PubMed ID: 18723830 [Abstract] [Full Text] [Related]
26. Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis. Lehmann U, Wingen LU, Brakensiek K, Wedemeyer H, Becker T, Heim A, Metzig K, Hasemeier B, Kreipe H, Flemming P. Hum Mol Genet; 2007 Jun 01; 16(11):1335-42. PubMed ID: 17412760 [Abstract] [Full Text] [Related]
27. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma. Cho S, Lee JH, Cho SB, Yoon KW, Park SY, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Pathol Int; 2010 Mar 01; 60(3):203-11. PubMed ID: 20403046 [Abstract] [Full Text] [Related]
28. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Hellerbrand C, Mühlbauer M, Wallner S, Schuierer M, Behrmann I, Bataille F, Weiss T, Schölmerich J, Bosserhoff AK. Carcinogenesis; 2006 Jan 01; 27(1):64-72. PubMed ID: 16081515 [Abstract] [Full Text] [Related]
29. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M. Int J Oncol; 2008 Nov 01; 33(5):949-58. PubMed ID: 18949357 [Abstract] [Full Text] [Related]
30. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Wong IH, Lo YM, Yeo W, Lau WY, Johnson PJ. Clin Cancer Res; 2000 Sep 01; 6(9):3516-21. PubMed ID: 10999738 [Abstract] [Full Text] [Related]
31. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF, Zhu JD. Cell Res; 2003 Oct 01; 13(5):319-33. PubMed ID: 14672555 [Abstract] [Full Text] [Related]
32. [Effect of p16 gene on carcinogenesis of hepatitis B virus related hepatocellular carcinoma]. Wang ZW, Peng ZH, Li K, Qiu GQ, Zhang Y, Gu W. Zhonghua Zhong Liu Za Zhi; 2003 Jul 01; 25(4):356-8. PubMed ID: 12921565 [Abstract] [Full Text] [Related]
33. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma. Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J. Am J Clin Pathol; 2006 May 01; 125(5):740-6. PubMed ID: 16707376 [Abstract] [Full Text] [Related]
35. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma. Song J, Kim CJ, Cho YG, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS. J Gastroenterol Hepatol; 2006 Aug 01; 21(8):1286-9. PubMed ID: 16872311 [Abstract] [Full Text] [Related]
36. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation. Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS. Oncol Rep; 2011 Apr 01; 25(4):1053-62. PubMed ID: 21271221 [Abstract] [Full Text] [Related]
37. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. Su H, Zhao J, Xiong Y, Xu T, Zhou F, Yuan Y, Zhang Y, Zhuang SM. Mutat Res; 2008 May 10; 641(1-2):27-35. PubMed ID: 18358501 [Abstract] [Full Text] [Related]
38. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Narimatsu T, Tamori A, Koh N, Kubo S, Hirohashi K, Yano Y, Arakawa T, Otani S, Nishiguchi S. Intervirology; 2004 May 10; 47(1):26-31. PubMed ID: 15044833 [Abstract] [Full Text] [Related]
39. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients. Chang H, Yi B, Li L, Zhang HY, Sun F, Dong SQ, Cao Y. Exp Mol Pathol; 2008 Oct 10; 85(2):96-100. PubMed ID: 18691570 [Abstract] [Full Text] [Related]
40. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Kiran M, Chawla YK, Kaur J. Cancer Genet Cytogenet; 2009 Dec 10; 195(2):112-9. PubMed ID: 19963110 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]